ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,727.83
0.16%
US Tech 100
19,393.20
0.37%
다우존스 지수
42,148.19
0.06%
Bitcoin
63,802.68
0.75%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Hikma Pharmaceuticals Plc (HIK)

  7. Hikma Pharmaceuticals Plc (HIK) 뉴스

HIK

Hikma Pharmaceuticals (HIK)

Hikma Pharmaceuticals Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:HIK
일자시간출처헤드라인심볼기업
2024/09/2418:09RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
2024/09/1017:09Alliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
2024/09/1017:09Alliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
2024/09/1015:00RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma completes Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
2024/09/0320:46Alliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
2024/09/0320:46Alliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
2024/08/2101:15PR Newswire (US)Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention DayLSE:HIKHikma Pharmaceuticals Plc
2024/08/1604:18PR Newswire (US)KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 monthsLSE:HIKHikma Pharmaceuticals Plc
2024/08/1318:16Alliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
2024/08/1318:16Alliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
2024/08/1317:39RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
2024/08/0819:33Alliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
2024/08/0819:33Alliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
2024/08/0815:00RNS Regulatory NewsHikma Pharmaceuticals Plc Half-year ReportLSE:HIKHikma Pharmaceuticals Plc
2024/07/3000:08RNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
2024/07/1515:00RNS Regulatory NewsHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
2024/07/0122:47RNS Regulatory NewsHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
2024/06/2721:47RNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
2024/06/1717:14Alliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
2024/06/1717:14Alliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
2024/06/1715:00RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma acquires Xellia’s assetsLSE:HIKHikma Pharmaceuticals Plc
2024/06/1121:05Alliance NewsAlliance NewsIN THE KNOW: Citi lifts Hikma price target amid positive industry dataLSE:HIKHikma Pharmaceuticals Plc
2024/06/1121:05Alliance NewsAlliance NewsIN THE KNOW: Citi lifts Hikma price target amid positive industry dataLSE:HIKHikma Pharmaceuticals Plc
2024/06/0522:53RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
2024/05/0917:49RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
2024/04/2522:28RNS Regulatory NewsHikma Pharmaceuticals Plc Result of AGMLSE:HIKHikma Pharmaceuticals Plc
2024/04/2518:15Alliance NewsAlliance NewsHikma Pharmaceuticals backs outlook after making strong start to 2024LSE:HIKHikma Pharmaceuticals Plc
2024/04/2518:15Alliance NewsAlliance NewsHikma Pharmaceuticals backs outlook after making strong start to 2024LSE:HIKHikma Pharmaceuticals Plc
2024/04/2515:00RNS Regulatory NewsHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
2024/04/1718:42RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
 검색 관련기사 보기:LSE:HIK

최근 히스토리

COIN
SPAYUST
SpaceY Token
LSE
85DK
Gran.04 1m
BOV
TASA4F
FORJA TAURUS PN
LSE
BK50
Gemgart.23-1 73
EU
EBST5
Euronext ESG Biodiversit...
COIN
PLYBTC
NASDAQ
RUM
Rumble
NYSE
HBI
Hanesbrands
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유